Genome &'s chart data is dated 2026-10-08. There is no active technical signal. There are 0 published signal records.
Genome & last closed at ₩5,530 (+3.95%) on 2026-10-08. Listed on KOSDAQ. Trailing 12 months PER is -4.8×. Its overall grade ranks 244 of 308 stocks in Healthcare.
About this company
Genome & last closed at ₩5,530 (+3.95%) on 2026-10-08. Listed on KOSDAQ.
Details →Reported results
Position in sector
Healthcare · Overall C · 244/308
Valuation grade C+
Recent filings
DART · received recent list, not a complete filing history. Factual information, not investment advice.
Related stocks
- 에이비엘바이오Competitor
항체·면역항암 신약 개발 분야에서 국내 바이오 기업 경쟁 관계
- 보로노이Competitor
표적항암제 등 신약개발 파이프라인 경쟁
- HK이노엔Competitor
면역항암·신약개발 및 기술이전 경쟁
About Genome &
- What technical signals does Genome & (314130) have?
- Genome & current technical signals: no active technical signal.
- Is Genome & a cup-and-handle pattern?
- No. Genome & has no valid Cup signal right now.
- What published figures are available for Genome &?
- Market cap: KRW 177.56B. Trailing 12 months PER: -4.8×. Latest quarter PBR: 2.73×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Genome &, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.